Skip to main content
A

Ab&B Bio-Tech CO., LTD. JS — Investor Relations & Filings

Ticker · 2627 HKEX Manufacturing
Open in API
Filings indexed 55 across all filing types
Latest filing 2025-10-02 Regulatory Filings
Country HK Hong Kong
Listing HKEX 2627

About Ab&B Bio-Tech CO., LTD. JS

http://www.abbbio.com

Ab&B Bio-Tech CO., LTD. JS is a biopharmaceutical company engaged in the research, development, manufacturing, and commercialization of human vaccines and biological preparations that confer active immunity. The company's mission centers on developing globally innovative vaccines and utilizing new technologies to improve traditional vaccines. Its comprehensive pipeline targets infectious diseases and includes candidates across viral, bacterial, conjugate, subunit, and mRNA platforms. The primary commercial product is the Quadrivalent Subunit Influenza Vaccine, approved for individuals aged six months and above. Advanced pipeline assets, such as the 23-valent Pneumococcal Polysaccharide Vaccine and the Freeze-dried Human Rabies Vaccine (Human Diploid Cell), have completed Phase I clinical trials. R&D operations are supported by facilities in Shanghai and Taizhou, with the company emphasizing scientific validation through publications in international journals.

Recent filings

Filing Released Lang Actions
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 SEPTEMBER 2025
Regulatory Filings Classification · 1% confidence The document is a “Monthly Return for Equity Issuer and Hong Kong Depositary Receipts” filed under Chapter 19B of the HKEX Listing Rules, detailing share capital and movements in issued shares. This is a routine periodic disclosure required by the exchange, and does not correspond to any of the specific categories such as Annual Report (10-K), Interim Report (IR), Share Issue (SHA), or Share Repurchase (POS). It is not simply a notice of publication; it is the regulatory report itself. Therefore it falls under the general “Regulatory Filings” category (RNS).
2025-10-02 English
Notification Letter to Non-registered Holders of H Shares and Request Form - Arrangement of Electronic Dissemination of Corporate Communications
Regulatory Filings Classification · 1% confidence The document is a shareholder notice concerning the electronic dissemination of corporate communications and a request form for printed copies, issued under the Listing Rules. It is not an annual or interim report, earnings release, AGM material, or any standard financial report. Rather, it is a regulatory announcement of how and where corporate communications will be published going forward, with no specific financial content. This best fits the fallback category for miscellaneous regulatory announcements (Regulatory Filings).
2025-09-29 English
Notification Letter to Registered H Shareholders - Arrangement of Electronic Dissemination of Corporate Communications
Regulatory Filings Classification · 1% confidence The document is a letter to shareholders regarding the arrangements for electronic and printed dissemination of all future corporate communications under the Hong Kong Listing Rules. It does not contain financial results, proxy voting materials for a specific meeting, or any other substantive report; rather it is a regulatory notification about communication procedures. This falls under the miscellaneous regulatory announcements category. Therefore, the correct classification is Regulatory Filings (RNS).
2025-09-29 English
2025 INTERIM REPORT
Interim / Quarterly Report Classification · 1% confidence The document is titled '2025 INTERIM REPORT' for Ab&B Bio-Tech CO., LTD. It contains comprehensive financial statements (Statement of Profit or Loss, Financial Position, Changes in Equity, Cash Flows), notes to the financial statements, and a detailed Management Discussion and Analysis (MDA) section covering the six-month period ended June 30, 2025. This meets the definition of an Interim/Quarterly Report (IR). H1 2025
2025-09-29 English
VOLUNTARY ANNOUNCEMENT - APPROVAL OF OUR APPLICATION FOR QUADRIVALENT SUBUNIT INFLUENZA VACCINE BY THE NMPA
Regulatory Filings Classification · 1% confidence The document is a voluntary corporate announcement regarding the approval of a vaccine by the National Medical Products Administration. It is not a financial report (10-K, IR, ER), not governance or board change, not capital/financing update, and does not fit other defined categories. It is a general regulatory/business update, so the appropriate fallback category is Regulatory Filings (RNS).
2025-09-03 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 AUGUST 2025
Regulatory Filings Classification · 1% confidence The document is a routine Monthly Return (Form FF301) submitted to the Hong Kong Stock Exchange covering movements in authorised share capital, issued shares, and other securities matters under Chapter 19B of the HKEX Listing Rules. It is not an AGM presentation, earnings release, or annual/interim report but a regulatory return filed under listing rules. It does not announce a report publication nor provide financial results or management commentary. Therefore, it best fits the fallback category for general regulatory filings.
2025-09-03 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.